Agency Information Collection Activities; Proposed Collection; Comment Request; FTC File No. P144504
I work to educate communities about the problem of tobacco use, including how the industry drives that use. In my community education activities, as more fully described below, I use the information FTC collects and shares about tobacco industry marketing. This data is an effective resource for community education and supports the development of evidence-based policies to counter industry activities and improve public health. Tobacco point of sale marketing has been an effective tactic to recruit new "replacement" smokersprimarily youthand to maintain use by existing customers. Retail tobacco marketing increases the likelihood that adolescents will initiate tobacco use and thwarts cessation attempts by current users. ENDS marketing of today mimics traditional cigarette marketing of the past and may have similar effects on initiation of ENDS use by youth. Additionally, given the entry of major tobacco companies into the ENDS market, the industry is likely to continue to use the same marketing techniques for ENDS that were successful in increasing sales of cigarettes and other tobacco products. In fact, expenditures on ENDS promotion has increased sharply in recent years, particularly through media no longer available to traditional tobacco products (like television) and primarily by the brands owned by large traditional tobacco companies (Altria's MarkTen, R.J. Reynolds 6 Tobacco Company's Vuse, and Imperial Tobacco's blu). This advertising is effectively reaching youth; there is high awareness of ENDS advertising among youth and young adults, particularly at the point of sale. This trend is disturbing given the rising popularity of ENDS among youth. It is vital for residents, public health professionals and policymakers to know how marketing and sales affect the community, particularly as it pertains to rising youth use of ENDS. Information about cigarette and smokeless tobacco marketing has been an important tool for the development of evidence-based public health policies.